# Jack Kruse DHA and Seafood Claims: Omega-3 Kernel vs Light-Physics Shell > Fatty fish guidance is mainstream. Electron-dense cold-water semiconductor fish is not. *Published 2026-07-10 · Updated 2026-07-10 · By Julian Hart* In short Kruse’s seafood/DHA emphasis mixes a **mainstream-compatible kernel** (fatty fish ~2×/week class guidance; EPA/DHA; fewer UPFs) with a **speculative shell** (DHA as light-transducing metabolic commander; cold-water fish as electron-dense semiconductors). Grade A–B for fish/omega-3 endpoints depending on dose form; **speculative** for quantum-light hierarchies. You can eat salmon for EPA and DHA without joining a physics cosplay. That is the entire editorial job. *This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.* ## What does Kruse actually prescribe around fish and oils? Leptin Rx and Epi-Paleo-linked materials emphasize high protein and fat breakfasts including fish, prescription-style fish oil titrated to markers in his writing, and avoidance of industrial seed oils early. Cold-thermogenesis posts discuss omega-six to omega-three ratio targets and preference for cold pelagic fish. Secondary teachers amplify evolutionary DHA–melanin–light stories. Primary texts live on jackkruse.com; grade claims, do not outsource clinical authority. ## Where does independent evidence align? ACC/AHA-style fish intake summaries support regular fatty fish for cardiovascular patterns. Li and colleagues’ 2022-style reviews highlight that pure EPA trials differ from mixed oils. Retinal and neural DHA structural roles are real lipid biology. Diets high in refined carbohydrates and imbalanced fats associate with metabolic risk in broader literature—not uniquely discovered by one protocol. Key reference points Claim layerGrade ~2 fatty fish servings/weekA/B guidance-class Retinal/brain DHA structural roleA/B biology EPA CV trial nuanceB (dose-form specific) Electron-dense fish physics hierarchySpeculative Epi-Paleo as universal disease RxD / weak vs guidelines ## Where do formulations overextend? Electron density of fish via cold-water semiconductor physics is not a clinical endpoint. Ranking fish primarily by coherence metaphors over mercury and EPA/DHA content confuses risk management. Claiming light outranks food as epidemic cause is a different article—and still speculative. Epi-Paleo purity is not proven superior to Mediterranean patterns for hard population endpoints. ## What dual-sourced practical guidance remains? Aim for roughly two fatty-fish servings weekly when appropriate; prefer food-first omega-threes; discuss supplements with dose and purity caveats; screen predatory fish in pregnancy and high consumers. Keep UV and contaminant literacy when promoting seafood and sun stacks. Sources: [Kruse Leptin Rx / Epi-Paleo notes](https://jackkruse.com/my-leptin-prescription/); [ACC fish intake summary](https://www.acc.org/latest-in-cardiology/articles/2021/11/01/12/41/fish-intake-fish-oil-and-cardiovascular-health); [Li 2022 omega-3 CV nuance](https://pmc.ncbi.nlm.nih.gov/articles/PMC9791266/). Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes. ## Sources 1. [Kruse Leptin Rx / Epi-Paleo notes](https://jackkruse.com/my-leptin-prescription/) 2. [ACC fish intake summary](https://www.acc.org/latest-in-cardiology/articles/2021/11/01/12/41/fish-intake-fish-oil-and-cardiovascular-health) 3. [Li 2022 omega-3 CV nuance](https://pmc.ncbi.nlm.nih.gov/articles/PMC9791266/) --- Source: https://healthcanon.com/expert-dossiers/jack-kruse-dha-seafood-claims Index: https://healthcanon.com/llms.txt · Full text: https://healthcanon.com/llms-full.txt